Stéphanie Dulucq

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

Stéphanie Dulucq, Stéphane Bouchet, Béatrice Turcq et al. · Blood · 2008 · 233 citations

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

Franck E. Nicolini, Stéphanie Dulucq, Lisa Boureau et al. · Clinical Cancer Research · 2019 · 108 citations · Full text

Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells

Romain Gioia, Cédric Leroy, Claire Drullion et al. · Blood · 2011 · 99 citations · Full text

DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL

Stéphanie Dulucq, Geneviève St‐Onge, Vincent Gagné et al. · Blood · 2007 · 97 citations

A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

Helen White, Liesbet Deprez, Philippe Corbisier et al. · Leukemia · 2014 · 81 citations · Full text